{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:04:16Z","timestamp":1790201056480,"version":"4.1.0"},"reference-count":61,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Metabolic dysfunction-associated steatotic liver disease (MASLD), characterized by hepatic steatosis, inflammation, and fibrosis, has reached epidemic proportions globally. Emerging evidence highlights a close association between amino acid metabolic dysregulation and MASLD pathogenesis, however, the precise mechanisms remain elusive. In this study, we identify pyrroline-5-carboxylate synthase (P5CS), a pivotal enzyme in proline biosynthesis, as a critical regulator of hepatic proline production and a key driver of MASLD progression. Based on comprehensive analysis of clinical samples from MASLD patients and experimental mouse models, we demonstrate that elevated hepatic and plasma proline levels, resulting from increased P5CS expression, are strongly correlated with disease severity. Genetic overexpression of P5CS in the livers of mice exacerbates diet-induced MASLD, whereas its knockdown exhibits protective profiles. Notably, proline supplementation abolishes the beneficial effects of P5CS knockdown, confirming the causal role of proline overproduction in MASLD pathogenesis. Mechanistically, P5CS-mediated proline accumulation impairs mitochondrial function, thereby disrupting fatty acid oxidation and promoting hepatic lipid accumulation. Pharmacological inhibition of P5CS activity could restore mitochondrial capacity. Thus, our findings establish P5CS-regulated proline metabolism as a novel pathogenic mechanism of MASLD and provide a potential approach for MASLD therapy.<\/jats:p>","DOI":"10.1093\/lifemeta\/loaf040","type":"journal-article","created":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T12:51:41Z","timestamp":1763211101000},"source":"Crossref","is-referenced-by-count":2,"title":["P5CS-coupled proline metabolism manipulates metabolic dysfunction-associated steatotic liver disease"],"prefix":"10.1093","volume":"5","author":[{"given":"Zan","family":"Lyu","sequence":"first","affiliation":[{"name":"Department of Pharmacology, School of Pharmacy, Fudan University , Shanghai 201203,","place":["China"]},{"name":"State Key Laboratory of Chemical Biology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Shanghai 201203,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sike","family":"Yu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Glyco-drug Research of Zhejiang Province, School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences , Hangzhou, Zhejiang 310024,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Peng","sequence":"additional","affiliation":[{"name":"Key Laboratory of Glyco-drug Research of Zhejiang Province, School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences , Hangzhou, Zhejiang 310024,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbiao","family":"Wu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Glyco-drug Research of Zhejiang Province, School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences , Hangzhou, Zhejiang 310024,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhua","family":"Yang","sequence":"additional","affiliation":[{"name":"School of Life Science and Technology, Shanghai Tech University , Shanghai 201210,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Ma","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Chemical Biology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Shanghai 201203,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Sun","sequence":"additional","affiliation":[{"name":"School of Life Science and Technology, Shanghai Tech University , Shanghai 201210,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liya","family":"Jing","sequence":"additional","affiliation":[{"name":"School of Life Science and Technology, Shanghai Tech University , Shanghai 201210,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Gu","sequence":"additional","affiliation":[{"name":"School of Life Science and Technology, Shanghai Tech University , Shanghai 201210,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erjiang","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Yangpu Hospital, School of Medicine, Tongji University , Shanghai 200090,","place":["China"]},{"name":"Center for Clinical Research and Translational Medicine, Yangpu Hospital, School of Medicine, Tongji University , Shanghai 200090,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Pharmacy, Fudan University , Shanghai 201203,","place":["China"]},{"name":"School of Pharmacy, East China Normal University , Shanghai 200241,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihong","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Yangpu Hospital, School of Medicine, Tongji University , Shanghai 200090,","place":["China"]},{"name":"Center for Clinical Research and Translational Medicine, Yangpu Hospital, School of Medicine, Tongji University , Shanghai 200090,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4419-7645","authenticated-orcid":false,"given":"Haowen","family":"Jiang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Chemical Biology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Shanghai 201203,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Chemical Biology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Shanghai 201203,","place":["China"]},{"name":"Key Laboratory of Glyco-drug Research of Zhejiang Province, School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences , Hangzhou, Zhejiang 310024,","place":["China"]},{"name":"School of Life Science and Technology, Shanghai Tech University , Shanghai 201210,","place":["China"]},{"name":"Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan Tsuihang New District , Zhongshan, Guangdong 528400,","place":["China"]},{"name":"Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery , Yantai, Shandong 264117,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"2026042522314582900_loaf040-B1","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41575-022-00635-5","article-title":"Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight","volume":"19","author":"Eslam","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2026042522314582900_loaf040-B2","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1053\/j.gastro.2020.01.043","article-title":"Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"158","author":"Taylor","year":"2020","journal-title":"Gastroenterology"},{"key":"2026042522314582900_loaf040-B3","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1007\/s12072-024-10660-y","article-title":"MAFLD as part of systemic metabolic dysregulation","volume":"18","author":"Zhao","year":"2024","journal-title":"Hepatol Int"},{"key":"2026042522314582900_loaf040-B4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41572-025-00599-1","article-title":"Metabolic dysfunction-associated steatotic liver disease in adults","volume":"11","author":"Huang","year":"2025","journal-title":"Nat Rev Dis Primers"},{"key":"2026042522314582900_loaf040-B5","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41574-022-00711-5","article-title":"Metabolic mechanisms for and treatment of NAFLD or NASH occurring after liver transplantation","volume":"18","author":"Lonardo","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"2026042522314582900_loaf040-B6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2026042522314582900_loaf040-B7","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1016\/j.cgh.2023.04.018","article-title":"Health-related quality of life in patients with nonalcoholic fatty liver disease: a prospective multi-center UK study","volume":"21","author":"Papatheodoridi","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026042522314582900_loaf040-B8","doi-asserted-by":"crossref","first-page":"e000106","DOI":"10.1136\/bmjgast-2016-000106","article-title":"Assessment of health utilities and quality of life in patients with non-alcoholic fatty liver disease","volume":"3","author":"Sayiner","year":"2016","journal-title":"BMJ Open Gastroenterol"},{"key":"2026042522314582900_loaf040-B9","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.jhep.2023.05.007","article-title":"Therapeutic opportunities for the treatment of NASH with genetically validated targets","volume":"79","author":"Lind\u00e9n","year":"2023","journal-title":"J Hepatol"},{"key":"2026042522314582900_loaf040-B10","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1111\/liv.15930","article-title":"The first MASH drug therapy on the horizon: current perspectives of resmetirom","volume":"44","author":"Petta","year":"2024","journal-title":"Liver Int"},{"key":"2026042522314582900_loaf040-B11","doi-asserted-by":"crossref","first-page":"1291501","DOI":"10.3389\/fmed.2024.1291501","article-title":"Metabolic-associated fatty liver disease: a selective review of pathogenesis, diagnostic approaches, and therapeutic strategies","volume":"11","author":"Habibullah","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"2026042522314582900_loaf040-B12","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s12933-022-01697-0","article-title":"Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention","volume":"21","author":"Zhou","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"2026042522314582900_loaf040-B13","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/s41467-023-37142-3","article-title":"Deficiency of gluconeogenic enzyme PCK1 promotes metabolic-associated fatty liver disease through PI3K\/AKT\/PDGF axis activation in male mice","volume":"14","author":"Ye","year":"2023","journal-title":"Nat Commun"},{"key":"2026042522314582900_loaf040-B14","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41575-018-0009-6","article-title":"Triggering and resolution of inflammation in NASH","volume":"15","author":"Schuster","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2026042522314582900_loaf040-B15","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.it.2022.09.002","article-title":"Linking nutrient sensing, mitochondrial function, and PRR immune cell signaling in liver disease","volume":"43","author":"Kemper","year":"2022","journal-title":"Trends Immunol"},{"key":"2026042522314582900_loaf040-B16","doi-asserted-by":"crossref","first-page":"102584","DOI":"10.1016\/j.clinre.2025.102584","article-title":"Metabolic dysfunction-associated steatotic liver disease (MASLD): exploring systemic impacts and innovative therapies","volume":"49","author":"Jain","year":"2025","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"2026042522314582900_loaf040-B17","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41392-022-01119-3","article-title":"Targeted therapeutics and novel \u00adsignaling pathways in non-alcohol-associated fatty liver\/\u00adsteatohepatitis (NAFL\/NASH)","volume":"7","author":"Xu","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"2026042522314582900_loaf040-B18","doi-asserted-by":"crossref","first-page":"603926","DOI":"10.3389\/fphar.2020.603926","article-title":"Non-alcoholic steatohepatitis: a review of its mechanism, models and medical treatments","volume":"11","author":"Peng","year":"2020","journal-title":"Front Pharmacol"},{"key":"2026042522314582900_loaf040-B19","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev-pathol-020117-043617","article-title":"Recent insights into the pathogenesis of nonalcoholic fatty liver disease","volume":"13","author":"Arab","year":"2018","journal-title":"Annu Rev Pathol"},{"key":"2026042522314582900_loaf040-B20","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/978-981-15-7360-6_20","article-title":"Molecular mechanisms of nonalcoholic fatty liver disease (NAFLD)\/nonalcoholic steatohepatitis (NASH)","volume":"1261","author":"Ota","year":"2021","journal-title":"Adv Exp Med Biol"},{"key":"2026042522314582900_loaf040-B21","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1478-3231.2010.02248.x","article-title":"Apoptosis is associated with CD36\/fatty acid translocase upregulation in non-alcoholic steatohepatitis","volume":"30","author":"Bechmann","year":"2010","journal-title":"Liver Int"},{"key":"2026042522314582900_loaf040-B22","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev-pathol-012615-044224","article-title":"Nonalcoholic fatty liver disease: pathogenesis and disease spectrum","volume":"11","author":"Hardy","year":"2016","journal-title":"Annu Rev Pathol"},{"key":"2026042522314582900_loaf040-B23","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J Clin Invest"},{"key":"2026042522314582900_loaf040-B24","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.gastro.2013.11.049","article-title":"Increased de\u00a0novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease","volume":"146","author":"Lambert","year":"2014","journal-title":"Gastroenterology"},{"key":"2026042522314582900_loaf040-B25","doi-asserted-by":"crossref","first-page":"e18816","DOI":"10.1371\/journal.pone.0018816","article-title":"Comparative gene expression profiles induced by PPAR\u03b3 and PPAR\u03b1\/\u03b3 agonists in human hepatocytes","volume":"6","author":"Rogue","year":"2011","journal-title":"PLoS One"},{"key":"2026042522314582900_loaf040-B26","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1016\/j.cmet.2024.07.023","article-title":"Glucagon promotes increased hepatic mitochondrial oxidation and pyruvate \u00adcarboxylase flux in humans with fatty liver disease","volume":"36","author":"Petersen","year":"2024","journal-title":"Cell Metab"},{"key":"2026042522314582900_loaf040-B27","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/hep.22306","article-title":"Toll-like receptors and adaptor molecules in liver disease: update","volume":"48","author":"Seki","year":"2008","journal-title":"Hepatology"},{"key":"2026042522314582900_loaf040-B28","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00431-014-2476-2","article-title":"The intestinal microbiota: its role in health and disease","volume":"174","author":"Biedermann","year":"2015","journal-title":"Eur J Pediatr"},{"key":"2026042522314582900_loaf040-B29","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1126\/science.1160794","article-title":"A stress signaling pathway in adipose tissue regulates hepatic insulin resistance","volume":"322","author":"Sabio","year":"2008","journal-title":"Science"},{"key":"2026042522314582900_loaf040-B30","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/90984","article-title":"The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity","volume":"7","author":"Yamauchi","year":"2001","journal-title":"Nat Med"},{"key":"2026042522314582900_loaf040-B31","doi-asserted-by":"crossref","first-page":"e004514","DOI":"10.1136\/bmjdrc-2024-004514","article-title":"Serum isthmin-1 is a potential biomarker for metabolic dysfunction associated fatty liver disease in patients with metabolic syndrome and type 2 diabetes mellitus","volume":"12","author":"Lei","year":"2024","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2026042522314582900_loaf040-B32","doi-asserted-by":"crossref","first-page":"1927633","DOI":"10.1080\/19490976.2021.1927633","article-title":"Gut Akkermansia muciniphila ameliorates metabolic dysfunction-associated fatty liver disease by regulating the metabolism of L-aspartate via gut-liver axis","volume":"13","author":"Rao","year":"2021","journal-title":"Gut Microbes"},{"key":"2026042522314582900_loaf040-B33","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.cmet.2023.12.013","article-title":"Serine synthesis via reversed SHMT2 activity drives glycine depletion and acetaminophen hepatotoxicity in MASLD","volume":"36","author":"Ghrayeb","year":"2024","journal-title":"Cell Metab"},{"key":"2026042522314582900_loaf040-B34","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.cmet.2020.01.013","article-title":"Targeting hepatic glutaminase 1 ameliorates non-alcoholic steatohepatitis by restoring very-low-density lipoprotein triglyceride assembly","volume":"31","author":"Simon","year":"2020","journal-title":"Cell Metab"},{"key":"2026042522314582900_loaf040-B35","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cca.2022.12.014","article-title":"Serum metabolomics-based heterogeneities and screening strategy for metabolic dysfunction-associated fatty liver disease (MAFLD)","volume":"538","author":"Shao","year":"2023","journal-title":"Clin Chim Acta"},{"key":"2026042522314582900_loaf040-B36","doi-asserted-by":"crossref","first-page":"728576","DOI":"10.3389\/fcell.2021.728576","article-title":"The multifaceted roles of proline in cell behavior","volume":"9","author":"Patriarca","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"2026042522314582900_loaf040-B37","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1007\/s00726-021-03051-2","article-title":"Proline metabolism and redox; maintaining a balance in health and disease","volume":"53","author":"Vettore","year":"2021","journal-title":"Amino Acids"},{"key":"2026042522314582900_loaf040-B38","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1007\/s00726-021-03060-1","article-title":"Proline metabolism in cancer","volume":"53","author":"Geng","year":"2021","journal-title":"Amino Acids"},{"key":"2026042522314582900_loaf040-B39","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/s42255-024-01206-5","article-title":"Proline exacerbates hepatic gluconeogenesis via paraspeckle-dependent mRNA retention","volume":"7","author":"Zhao","year":"2025","journal-title":"Nat Metab"},{"key":"2026042522314582900_loaf040-B40","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.3390\/nu12051450","article-title":"Changed amino acids in NAFLD and liver fibrosis: a large cross-sectional study without influence of insulin resistance","volume":"12","author":"Hasegawa","year":"2020","journal-title":"Nutrients"},{"key":"2026042522314582900_loaf040-B41","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.clinbiochem.2016.05.016","article-title":"Serum metabonomics of NAFLD plus T2DM based on liquid chromatography-mass spectrometry","volume":"49","author":"Chen","year":"2016","journal-title":"Clin Biochem"},{"key":"2026042522314582900_loaf040-B42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2022.10.007","article-title":"Glutaminase 1 blockade alleviates nonalcoholic steatohepatitis via promoting proline metabolism","volume":"634","author":"Tu","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"key":"2026042522314582900_loaf040-B43","doi-asserted-by":"crossref","first-page":"7873","DOI":"10.1021\/acs.jafc.5b02830","article-title":"Mass-spectrometry-based serum metabolomics of a C57BL\/6J mouse model of high-fat-diet-induced non-alcoholic fatty liver disease development","volume":"63","author":"Lai","year":"2015","journal-title":"J\u00a0Agric Food Chem"},{"key":"2026042522314582900_loaf040-B44","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41418-020-0601-5","article-title":"Pyrroline-5-carboxylate synthase senses cellular stress and modulates metabolism by regulating mitochondrial respiration","volume":"28","author":"Yang","year":"2021","journal-title":"Cell Death Differ"},{"key":"2026042522314582900_loaf040-B45","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s00018-023-05061-7","article-title":"Contributing roles of mitochondrial dysfunction and hepatocyte apoptosis in liver diseases through oxidative stress, post-translational modifications, inflammation, and intestinal barrier dysfunction","volume":"81","author":"LeFort","year":"2024","journal-title":"Cell Mol Life Sci"},{"key":"2026042522314582900_loaf040-B46","doi-asserted-by":"crossref","first-page":"bqab175","DOI":"10.1210\/endocr\/bqab175","article-title":"Rosiglitazone requires hepatocyte PPAR\u03b3 expression to promote steatosis in male mice with diet-induced obesity","volume":"162","author":"Lee","year":"2021","journal-title":"Endocrinology"},{"key":"2026042522314582900_loaf040-B47","doi-asserted-by":"crossref","first-page":"9453","DOI":"10.3390\/nu7115475","article-title":"The subtle balance between lipolysis and lipogenesis: a critical point in metabolic homeostasis","volume":"7","author":"Saponaro","year":"2015","journal-title":"Nutrients"},{"key":"2026042522314582900_loaf040-B48","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1080\/14728222.2021.2018418","article-title":"PNPLA3 as a therapeutic target for fatty liver disease: the evidence to date","volume":"25","author":"Cherubini","year":"2021","journal-title":"Expert Opin Ther Targets"},{"key":"2026042522314582900_loaf040-B49","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1038\/s42255-023-00919-3","article-title":"Inhibition of the proline metabolism rate-limiting enzyme P5CS allows proliferation of glutamine-restricted cancer cells","volume":"5","author":"Linder","year":"2023","journal-title":"Nat Metab"},{"key":"2026042522314582900_loaf040-B50","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1152\/physrev.00037.2016","article-title":"Arginase: a multifaceted enzyme important in health and disease","volume":"98","author":"Caldwell","year":"2018","journal-title":"Physiol Rev"},{"key":"2026042522314582900_loaf040-B51","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/s10038-019-0614-4","article-title":"Urea cycle disorders\u2014update","volume":"64","author":"Matsumoto","year":"2019","journal-title":"J Hum Genet"},{"key":"2026042522314582900_loaf040-B52","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1111\/liv.14205","article-title":"Non-alcoholic fatty liver disease alters expression of genes governing hepatic nitrogen conversion","volume":"39","author":"Eriksen","year":"2019","journal-title":"Liver Int"},{"key":"2026042522314582900_loaf040-B53","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/j.cmet.2024.07.007","article-title":"Hierarchical tricarboxylic acid cycle regulation by hepatocyte arginase 2 links the urea cycle to oxidative metabolism","volume":"36","author":"Zhang","year":"2024","journal-title":"Cell Metab"},{"key":"2026042522314582900_loaf040-B54","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0021-9258(17)37853-5","article-title":"The biosynthetic route from ornithine to proline","volume":"254","author":"Mestichelli","year":"1979","journal-title":"J Biol Chem"},{"key":"2026042522314582900_loaf040-B55","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1158\/1078-0432.CCR-17-1707","article-title":"Global metabolic profiling identifies a pivotal role of proline and hydroxyproline metabolism in supporting hypoxic response in hepatocellular carcinoma","volume":"24","author":"Tang","year":"2018","journal-title":"Clin Cancer Res"},{"key":"2026042522314582900_loaf040-B56","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jhep.2019.10.026","article-title":"Metabolic pathway analyses identify proline biosynthesis pathway as a promoter of liver tumorigenesis","volume":"72","author":"Ding","year":"2020","journal-title":"J Hepatol"},{"key":"2026042522314582900_loaf040-B57","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1038\/s41388-025-03456-3","article-title":"P5CS deacetylation mediated by SIRT2 facilitates tumor growth by enhancing mitochondrial respiration in hepatocellular carcinoma","volume":"44","author":"Geng","year":"2025","journal-title":"Oncogene"},{"key":"2026042522314582900_loaf040-B58","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1007\/s12094-023-03137-1","article-title":"Identification of acetyl-coA carboxylase alpha as a prognostic and targeted candidate for hepatocellular carcinoma","volume":"25","author":"Shen","year":"2023","journal-title":"Clin Transl Oncol"},{"key":"2026042522314582900_loaf040-B59","doi-asserted-by":"crossref","first-page":"951","DOI":"10.7150\/jca.52778","article-title":"Targeted inhibition of ACLY expression to reverse the resistance of sorafenib in hepatocellular carcinoma","volume":"13","author":"Sun","year":"2022","journal-title":"J Cancer"},{"key":"2026042522314582900_loaf040-B60","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12943-025-02274-1","article-title":"Modulating lipid metabolism by nanoparticles (NPs)-mediated ACSL3 silencing to inhibit hepatocellular carcinoma growth and metastasis","volume":"24","author":"Huang","year":"2025","journal-title":"Mol Cancer"},{"key":"2026042522314582900_loaf040-B61","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13046-022-02567-z","article-title":"Targeting fatty acid synthase modulates sensitivity of hepatocellular carcinoma to sorafenib via ferroptosis","volume":"42","author":"Li","year":"2023","journal-title":"J Exp Clin Cancer Res"}],"container-title":["Life Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/lifemeta\/advance-article-pdf\/doi\/10.1093\/lifemeta\/loaf040\/65397133\/loaf040.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/lifemeta\/article-pdf\/5\/2\/loaf040\/65397133\/loaf040.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/lifemeta\/article-pdf\/5\/2\/loaf040\/65397133\/loaf040.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T02:31:58Z","timestamp":1777170718000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/lifemeta\/article\/doi\/10.1093\/lifemeta\/loaf040\/8328310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4,24]]}},"URL":"https:\/\/doi.org\/10.1093\/lifemeta\/loaf040","relation":{},"ISSN":["2755-0230"],"issn-type":[{"value":"2755-0230","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2025,11,19]]},"article-number":"loaf040"}}